| Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, ... Molecular psychiatry 23 (5), 1261, 2018 | 116 | 2018 |
| Predictors of substance use among homeless youth in San Diego CA Bousman, EJ Blumberg, AM Shillington, MF Hovell, M Ji, S Lehman, ... Addictive behaviors 30 (6), 1100-1110, 2005 | 97 | 2005 |
| Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study J Sarris, C Stough, CA Bousman, ZT Wahid, G Murray, R Teschke, ... Journal of clinical psychopharmacology 33 (5), 643-648, 2013 | 87 | 2013 |
| Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples CA Bousman, G Chana, SJ Glatt, SD Chandler, GR Lucero, E Tatro, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010 | 78 | 2010 |
| ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression AB Singh, CA Bousman, CH Ng, K Byron, M Berk Translational psychiatry 2 (11), e198, 2012 | 75 | 2012 |
| Genetic association studies of methamphetamine use disorders: a systematic review and synthesis CA Bousman, SJ Glatt, IP Everall, MT Tsuang American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009 | 72 | 2009 |
| Commercial pharmacogenetic-based decision-support tools in psychiatry CA Bousman, M Hopwood The Lancet Psychiatry 3 (6), 585-590, 2016 | 55 | 2016 |
| Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV CA Bousman, M Cherner, C Ake, S Letendre, JH Atkinson, TL Patterson, ... Journal of affective disorders 119 (1-3), 84-91, 2009 | 52 | 2009 |
| Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis SJ Glatt, C Bousman, RS Wang, KK Murthy, BK Rana, JA Lasky-Su, ... Drug and alcohol dependence 90 (2-3), 159-165, 2007 | 49 | 2007 |
| White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs P Klauser, ST Baker, VL Cropley, C Bousman, A Fornito, L Cocchi, ... Schizophrenia bulletin 43 (2), 425-435, 2017 | 46 | 2017 |
| Accelerated gray and white matter deterioration with age in schizophrenia VL Cropley, P Klauser, RK Lenroot, J Bruggemann, S Sundram, ... American Journal of Psychiatry 174 (3), 286-295, 2016 | 45 | 2016 |
| Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings M Cherner, C Bousman, I Everall, D Barron, S Letendre, F Vaida, ... Journal of the International Neuropsychological Society 16 (5), 890-901, 2010 | 43 | 2010 |
| Antidepressant pharmacogenetics AB Singh, CA Bousman, C Ng, M Berk Current opinion in psychiatry 27 (1), 43-51, 2014 | 42 | 2014 |
| Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood CA Bousman, G Chana, SJ Glatt, SD Chandler, T May, J Lohr, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010 | 41 | 2010 |
| Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table) SJ Glatt, SD Chandler, CA Bousman, G Chana, GR Lucero, E Tatro, ... Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2009 | 37 | 2009 |
| Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools CA Bousman, M Forbes, M Jayaram, H Eyre, CF Reynolds, M Berk, ... BMC psychiatry 17 (1), 60, 2017 | 36 | 2017 |
| Neuregulin-1 and schizophrenia in the genome-wide association study era MS Mostaid, D Lloyd, B Liberg, S Sundram, A Pereira, C Pantelis, T Karl, ... Neuroscience & Biobehavioral Reviews 68, 387-409, 2016 | 36 | 2016 |
| Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects J Sarris, C Stough, R Teschke, ZT Wahid, CA Bousman, G Murray, ... Phytotherapy Research 27 (11), 1723-1728, 2013 | 34 | 2013 |
| Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis G Chana, CA Bousman, TT Money, A Gibbons, P Gillett, B Dean, ... Frontiers in cellular neuroscience 7, 95, 2013 | 33 | 2013 |
| Effects of oxytocin and genetic variants on brain and behaviour: implications for treatment in schizophrenia CF Bartholomeusz, EP Ganella, I Labuschagne, C Bousman, C Pantelis Schizophrenia research 168 (3), 614-627, 2015 | 32 | 2015 |
Gursharan ChanaCentre for Neural Engineering, The University of MelbourneVerified email at unimelb.edu.au
